On June 12, Shi Dai, General Manager of China Merchants Group, conducted a field research on Renfu Pharmaceutical Group in Yichang, listened to a briefing, conducted an on-site inspection of the core subsidiary Yichang Renfu, and gave important work instructions. Wu Bo, Chief Accountant of China Merchants Group; relevant department heads of China Merchants Group; relevant personnel from China Merchants Innovation, China Merchants Bank, China Changjiang Navigation, China Merchants Transportation, and China Merchants Shekou attended the research.

Du Wentao, President of Renfu Pharmaceutical Group, introduced the history, development strategy, operating performance, industry and international development layout, and future development plans of Renfu Pharmaceutical, and stated that Renfu Pharmaceutical will quickly integrate into the overall strategy of China Merchants Group, actively participate in the third entrepreneurial phase of China Merchants Group, and play a pioneering role.

Shi Dai pointed out that since its establishment, Renfu Pharmaceutical Group has experienced hardships and achieved great success, developing into a modern pharmaceutical enterprise with a profound foundation, broad prospects, and strong competitiveness. Shi Dai stated that China Merchants Group attaches great importance to and has high expectations for Renfu Pharmaceutical, and will plan for more far-reaching development in the future, hoping that Renfu Pharmaceutical and China Merchants Group will achieve a two-way journey towards a brighter future. Shi Dai emphasized that the future strategic focus of China Merchants Group is on science and technology innovation industries. The pharmaceutical and health industry is both a traditional industry and an innovative future industry, and is one of the three directions of "life science, digital intelligence technology, and green technology" anchored by China Merchants Innovation. Relying on the strong competitiveness of China Merchants Group in transportation and logistics, integrated finance, and real estate parks, Renfu Pharmaceutical will surely achieve better and faster development. Shi Dai affirmed the "MAGIC" business strategy proposed by China Merchants Innovation, and sincerely hoped that Renfu Pharmaceutical could continue to cultivate and develop, becoming a key and vibrant platform for the Group, working closely with related industries within the Group, accelerating the transformation of achievements, exploring broader markets, and creating a "magic" legend.

Shi Dai emphasized that the future work of Renfu Pharmaceutical should focus on four words: First, "stability." China Merchants Group's acquisition is to promote the better development of Renfu Pharmaceutical. The company should stabilize people's hearts, teams, and expectations. All employees should concentrate on production and operation and maintain a good momentum of steady progress. Second, "integration." For over a hundred years, China Merchants Group has upheld the innovative spirit of daring to be the first and taking the lead, providing a fundamental guarantee for the steady and far-reaching development of the enterprise. Renfu Pharmaceutical has also formed a good business management mechanism during its development. Its meticulous management and conscientious work style are highly compatible with China Merchants Group's pragmatic, innovative, and law-abiding culture. It is expected that the integration of the two will produce better products, build better teams, and further enhance organizational capabilities. Third, "innovation." Innovation is the foundation of an enterprise and the source of the team's innovative vitality. The innovative gene should be fully integrated into the enterprise's business philosophy, management mechanisms, and various systems, especially in terms of technological innovation, unremitting efforts should be made, investment should be increased, and more achievements should be produced. Fourth, "expansion." We should strive for higher goals, new progress, and outward expansion. We should not only focus on the domestic market but also go global. China Merchants Group's extensive overseas layout will provide rich resources for the company to expand its international market.

Shi Dai encouraged Renfu Pharmaceutical to continue innovating and reaching new heights, contributing more to the national pharmaceutical industry and people's health.

Yin Qiang, Vice President of Renfu Pharmaceutical Group and Chairman of Xinjiang Veyou; Liu Nanhong, Secretary of the Board of Directors; Li Jie, Chairman of Yichang Renfu, etc., participated in the event.

Article from Yichang Renfu Pharmaceutical